EUVIMEDScopri EUVIMED
Vergleichsstudie

Zero‐Fluoroscopy High‐Power Short‐Duration Ablation in Atrial Fibrillation: Safety, Efficacy, and Feasibility Comparison

Yayang Liu iD, He Li, Yuansheng Zhu, Lijuan Cao, Shuguang Zhang

Pacing and Clinical Electrophysiology · 2025

DOI: 10.1111/pace.70066 ↗

At a glance

Vergleichsstudie in Pacing and Clinical Electrophysiology, 2025. Written by Yayang Liu and 4 co-authors. Institution: Department of Cardiology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'An City, Jia…. Major MEDLINE topics: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Cited 1 times so far (Crossref); 23 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Atrial fibrillation (AF) is a common cardiac arrhythmia with significant morbidity. Catheter ablation is effective, but traditional fluoroscopic guidance carries radiation risks. This study compares zero‐fluoroscopy (ZF) with high‐power short‐duration (HPSD) ablation to conventional strategies in patients with symptomatic non‐valvular paroxysmal AF undergoing pulmonary vein isolation (PVI).

Methods

A retrospective analysis of 312 PVI patients was conducted, divided into three groups: control (fluoroscopy and conventional power), HPSD, and ZF combined with HPSD (ZF + HPSD). Outcomes measured were procedural success, safety, efficacy at 1‐year follow‐up, and complications.

Results

All groups achieved 100% PVI with similar first‐pass isolation rates. The ZF + HPSD group had no fluoroscopic time or radiation exposure and reduced septal puncture and left atrial (LA) mapping times compared to controls. Ablation and procedural times were shorter for HPSD and ZF + HPSD groups. One‐year freedom from atrial arrhythmia rates were not significantly different (Control: 78.8%; HPSD: 82.7%; ZF + HPSD: 85.6%; p = 0.205). No major complications were observed during follow‐up. LA diameter predicted AF recurrence.

Conclusion

The ZF + HPSD approach for AF ablation is feasible, safe, and effective, offering reduced radiation exposure. It was non‐inferior to HPSD in safety and efficacy at 1‐year follow‐up, suggesting broader clinical application potential.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationCatheter AblationPulmonary VeinsAgedFemaleHumansMaleMiddle AgedFeasibility StudiesFluoroscopyRetrospective StudiesTreatment Outcome

Author keywords

atrial fibrillationcatheter ablationhigh‐power short‐durationpulmonary vein isolationradiation exposurezero‐fluoroscopy

Authors and institutions

  • Department of Cardiology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'An City, Jiangsu Province, China.
  • Department of Cardiology, Huai'an Hospital of Traditional Chinese Medicine, Huai'An City, Jiangsu Province, China.

ORCID profiles: Yayang Liu

Cite

APA

Liu, Y., Li, H., Zhu, Y., Cao, L., & Zhang, S. (2025). Zero‐Fluoroscopy High‐Power Short‐Duration Ablation in Atrial Fibrillation: Safety, Efficacy, and Feasibility Comparison. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70066

Vancouver

Liu Y, Li H, Zhu Y, Cao L, Zhang S. Zero‐Fluoroscopy High‐Power Short‐Duration Ablation in Atrial Fibrillation: Safety, Efficacy, and Feasibility Comparison. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.70066

BibTeX
@article{Liu2025,
  author = {Liu, Yayang and Li, He and Zhu, Yuansheng and Cao, Lijuan and Zhang, Shuguang},
  title = {Zero‐Fluoroscopy High‐Power Short‐Duration Ablation in Atrial Fibrillation: Safety, Efficacy, and Feasibility Comparison},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2025},
  doi = {10.1111/pace.70066}
}
Start for free →